Risk factors of infection of totally implantable venous access port: A retrospective study

被引:2
|
作者
Guan, Xiaonan [1 ]
Yan, He [2 ]
Zhang, Jianjun [1 ]
Li, Yanbing [1 ]
Zhou, Yiming [2 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Cardiol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Intervent Dept, 5 Jingyuan Rd, Beijing 100043, Peoples R China
来源
JOURNAL OF VASCULAR ACCESS | 2023年 / 24卷 / 06期
关键词
Totally implantable venous access port; perioperative infection; complication; cancer patient; antibiotics; CLINICAL-PRACTICE; ANTIBIOTIC-PROPHYLAXIS; PRACTICE GUIDELINE; DEVICE PLACEMENT; CANCER; COMPLICATIONS; CATHETER; DIAGNOSIS; SOCIETY; SYSTEMS;
D O I
10.1177/11297298221085230
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Infection is the most frequent complication associated with the use of totally implantable venous access port (TIVAP). This retrospective study was conducted to determine the risk factors affecting TIVAP-related infection. Methods: A total of 1406 patients implanted with TIVAP at our center were included in this retrospective study. Incidence of perioperative infection, patient characteristics and bacteriologic data were retrieved and analyzed. Univariable analyses and multiple logistic regression analyses were used to determine the risk factors. Results: Overall, 72 (5.1%) patients had perioperative infection, and TIVAP was finally removed from 12 (0.85%) patients. There was significantly more hematologic malignancy in the infection group, compared to the non-infection group. Patients with chemotherapy and infection within 30 days before operation also had more infections. There were more inpatients in the infection group than in the non-infection group. The rate of hematoma was higher in the infected patients. Multivariate logistic analysis revealed that hematoma (OR 5.695, p < 0.001), preoperative hospital stay (> 14d) (OR 2.945, p < 0.001), history of chemotherapy (OR 2.628, p = 0.002), history of infection (within 30 days) (OR 4.325, p < 0.001) were independent risk factor for infection. Conclusions: This study demonstrated that hematoma, preoperative hospital stay (> 14d), history of chemotherapy and history of infection (within 30 days) are independent risk factor for all patients.
引用
收藏
页码:1340 / 1348
页数:9
相关论文
共 50 条
  • [1] Incidence and risk factor for infection of totally implantable venous access port
    Tung-Cheng Chang
    Min-Hsuan Yen
    Kee-Thai Kiu
    Langenbeck's Archives of Surgery, 2022, 407 : 343 - 351
  • [2] Incidence and risk factor for infection of totally implantable venous access port
    Chang, Tung-Cheng
    Yen, Min-Hsuan
    Kiu, Kee-Thai
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (01) : 343 - 351
  • [3] Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy
    Furuhashi, Satoru
    Morita, Yoshifumi
    Ida, Shinya
    Muraki, Ryuta
    Kitajima, Ryo
    Suzuki, Katsunori
    Takeda, Makoto
    Kikuchi, Hirotoshi
    Hiramatsu, Yoshihiro
    Kurachi, Kiyotaka
    Shido, Yoji
    Sugimoto, Ken
    Ito, Hiroaki
    Maekawa, Yuichiro
    Mineta, Hiroyuki
    Miyake, Hideaki
    Takeuchi, Hiroya
    ANTICANCER RESEARCH, 2021, 41 (03) : 1547 - 1553
  • [4] Risk factors for infection of totally implantable central venous access ports among patients requiring port removal
    Hara, Yuki
    Sumida, Yorihisa
    Yamazaki, Shoto
    Takei, Daiki
    Yamashita, Manpei
    Fukuda, Akiko
    Hisanaga, Makoto
    Tanaka, Takayuki
    Wakata, Koki
    Miyazaki, Takuro
    Araki, Masato
    Yano, Hiroshi
    Nakamura, Akihiro
    JOURNAL OF VASCULAR ACCESS, 2025, 26 (02): : 519 - 524
  • [5] Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching
    Nezami, Nariman
    Xing, Minzhi
    Groenwald, Matthew
    Silin, Douglas
    Kokabi, Nima
    Latich, Igor
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (09) : 1302 - 1310
  • [6] Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching
    Nariman Nezami
    Minzhi Xing
    Matthew Groenwald
    Douglas Silin
    Nima Kokabi
    Igor Latich
    CardioVascular and Interventional Radiology, 2019, 42 : 1302 - 1310
  • [7] Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study
    Viana Taveira, Michelle Ribeiro
    Lima, Luciana Santana
    de Araujo, Claudia Correa
    Goncalves de Mello, Maria Julia
    PEDIATRIC BLOOD & CANCER, 2017, 64 (02) : 336 - 342
  • [8] Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port
    Crisinel, M.
    Mahy, S.
    Ortega-Debalon, P.
    Buisson, M.
    Favre, J. -P.
    Chavanet, P.
    Piroth, L.
    MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (04): : 252 - 258
  • [9] Totally implantable central venous access port infections in patients with digestive cancer: Incidence and risk factors
    Toure, Abdoulaye
    Vanhems, Philippe
    Lombard-Bohas, Catherine
    Cassier, Philippe
    Pere-Verge, Denis
    Souquet, Jean-Christophe
    Ecochard, Rene
    Chambrier, Cecile
    AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (10) : 935 - 939
  • [10] Retrospective evaluation of totally implantable venous access port devices: Early and late complications
    Gurkan, Selami
    Seber, Selcuk
    Gur, Ozcan
    Yetisyigit, Tarkan
    Donbaloglu, Mehmet Okan
    Gur, Demet Ozkaramanli
    JOURNAL OF BUON, 2015, 20 (01): : 338 - 345